NO810870L - Fremgangsmaate til fremstilling av pyrimidylkinazoliner - Google Patents

Fremgangsmaate til fremstilling av pyrimidylkinazoliner

Info

Publication number
NO810870L
NO810870L NO810870A NO810870A NO810870L NO 810870 L NO810870 L NO 810870L NO 810870 A NO810870 A NO 810870A NO 810870 A NO810870 A NO 810870A NO 810870 L NO810870 L NO 810870L
Authority
NO
Norway
Prior art keywords
formula
compound
acid
atoms
amino
Prior art date
Application number
NO810870A
Other languages
English (en)
Norwegian (no)
Inventor
Heinz Bender
Thomas Raabe
Helmut Bohn
Piero Martorana
Original Assignee
Cassella Farbwerke Mainkur Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cassella Farbwerke Mainkur Ag filed Critical Cassella Farbwerke Mainkur Ag
Publication of NO810870L publication Critical patent/NO810870L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pretreatment Of Seeds And Plants (AREA)
  • Catching Or Destruction (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
NO810870A 1980-03-27 1981-03-13 Fremgangsmaate til fremstilling av pyrimidylkinazoliner NO810870L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803011809 DE3011809A1 (de) 1980-03-27 1980-03-27 Pyrimidyl-chinazoline, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung

Publications (1)

Publication Number Publication Date
NO810870L true NO810870L (no) 1981-09-28

Family

ID=6098481

Family Applications (1)

Application Number Title Priority Date Filing Date
NO810870A NO810870L (no) 1980-03-27 1981-03-13 Fremgangsmaate til fremstilling av pyrimidylkinazoliner

Country Status (18)

Country Link
EP (1) EP0037495A1 (cs)
JP (1) JPS56150088A (cs)
AR (1) AR227542A1 (cs)
AU (1) AU6877481A (cs)
CA (1) CA1156656A (cs)
CS (1) CS219898B2 (cs)
DD (1) DD157614A5 (cs)
DE (1) DE3011809A1 (cs)
DK (1) DK115581A (cs)
ES (1) ES8202000A1 (cs)
FI (1) FI810778A7 (cs)
GR (1) GR71870B (cs)
IL (1) IL62495A0 (cs)
NO (1) NO810870L (cs)
PL (2) PL230320A1 (cs)
PT (1) PT72724B (cs)
SU (1) SU1052158A3 (cs)
ZA (1) ZA812034B (cs)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61140568A (ja) * 1984-12-14 1986-06-27 Mitsui Petrochem Ind Ltd キナゾリン誘導体及びそれを有効成分とする血圧降下剤
JPS6267077A (ja) * 1985-09-18 1987-03-26 Mitsui Petrochem Ind Ltd キナゾリン誘導体及び医薬
CN102079743B (zh) * 2004-03-15 2020-08-25 武田药品工业株式会社 二肽基肽酶抑制剂
US7576076B2 (en) * 2004-07-02 2009-08-18 Corcept Therapeutics, Inc. Modified pyrimidine glucocorticoid receptor modulators
CN103596431B (zh) 2011-03-18 2016-06-22 科赛普特治疗公司 嘧啶环己基糖皮质激素受体调节剂
CA3102099C (en) 2018-06-04 2023-09-26 Corcept Therapeutics Incorporated Pyrimidine cyclohexenyl glucocorticoid receptor modulators
JP7569492B2 (ja) 2019-12-11 2024-10-18 コーセプト セラピューティクス， インコーポレイテッド 抗精神病薬誘発性体重増加のミリコリラントによる治療方法
KR102911885B1 (ko) 2020-05-06 2026-01-12 코어셉트 쎄라퓨틱스 인코포레이티드 피리미딘 사이클로헥실 글루코코르티코이드 수용체 조절제의 다형체
AU2021266739B2 (en) 2020-05-06 2024-11-28 Corcept Therapeutics Incorporated Formulations of pyrimidine cyclohexyl glucocorticoid receptor modulators
JP7853982B2 (ja) 2020-12-21 2026-04-30 コーセプト セラピューティクス， インコーポレイテッド ピリミジンシクロヘキシルグルココルチコイド受容体調節因子を調製する方法
US12616698B2 (en) 2021-05-05 2026-05-05 Corcept Therapeutics Incorporated Methods for reducing liver fat and for treating fatty liver disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2007656B (en) * 1977-11-05 1982-05-19 Pfizer Ltd Therapeutic agents

Also Published As

Publication number Publication date
SU1052158A3 (ru) 1983-10-30
PT72724B (de) 1982-03-24
ZA812034B (en) 1982-05-26
IL62495A0 (en) 1981-05-20
CS219898B2 (en) 1983-03-25
AU6877481A (en) 1981-10-01
PL233882A1 (cs) 1982-05-10
DK115581A (da) 1981-09-28
FI810778L (fi) 1981-09-28
FI810778A7 (fi) 1981-09-28
EP0037495A1 (de) 1981-10-14
DD157614A5 (de) 1982-11-24
JPS56150088A (en) 1981-11-20
DE3011809A1 (de) 1981-10-01
ES500738A0 (es) 1982-01-16
PL230320A1 (cs) 1982-03-29
ES8202000A1 (es) 1982-01-16
GR71870B (cs) 1983-07-08
AR227542A1 (es) 1982-11-15
CA1156656A (en) 1983-11-08
PT72724A (de) 1981-04-01

Similar Documents

Publication Publication Date Title
KR100446877B1 (ko) 알파1아드레날린수용체길항물질로서의피리미딘디온,피리미딘트리온,트리아진디온,테트라히드로퀴나졸린디온유도체
DE2912105C2 (de) Neue carbostyrilderivate, verfahren zu deren herstellung und diese enthaltende mittel
FI88504C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 4-benzyl-1-(2H)-ftalazinonderivat
DE69208263T2 (de) Substituierte aminopyrimidine als angiotensin ii antagonisten
US4746664A (en) Substituted-3,4-dihydro-4-(2,4,6-trimethoxyphenylimino)-2(1H)-pyrimidones useful as cardiotonic, antihypertensive, cerebrovascular vasodilator and anti-platelet agent
EP0168262A2 (en) Pyrimidine derivatives, processes for preparation thereof and use thereof
DE69413019T2 (de) Stickstoff enthaltende kondensierte heterocylen
NO115800B (cs)
PL212407B1 (pl) Zwiazek pochodny 8-chinolinoksantyny i 8-izochinolinoksantyny, jego zastosowanie, kompozycja farmaceutyczna zawierajaca zwiazek oraz sposób wytwarzania zwiazku
NO822643L (no) Fremgangsmaate til fremstilling av nye piperazinoner og deres anvendelse.
CA1265796A (en) Dihydropyridine anti-ischaemic and antihypertensive agents
JPH0351706B2 (cs)
HU200337B (en) Process for producing substituted 6-phenyldihydro-3/2h/-pyridazinone derivatives and pharmaceutical compositions comprising such compounds
JPS6354714B2 (cs)
NL194966C (nl) 3(2H)-Pyridazinonderivaten en werkwijze voor de bereiding ervan; farmaceutische samenstelling.
JPH0466B2 (cs)
CA1156656A (en) Process for the preparation of pyrimidyl-chinazolines
HU186975B (en) Process for preparing new triazolo-quinazolone derivatives
JP4472337B2 (ja) アルキルアミノピリダジノン誘導体、この調製方法、およびこれを含む医薬組成物
US4841051A (en) Phenylpiperazine derivatives
HU195786B (en) Process for producing 5-substituted-6-aminopyrimidine-derivatives and pharmaceutical preparations containing same
US4826845A (en) 3(2H)-pyridazinones and pharmaceutical compositions thereof
EP0145019A2 (en) Pyridazinone derivatives and salts thereof
US4847251A (en) Pyridazinone derivatives, and pharmaceutical compositions containing them
HUT76266A (en) New piperazinyl-alkylthio-pyrimidine derivatives, pharmaceutical compositions containing them, and process for producing the active components